FS Bancorp (FSBW) insider filing: Degner awarded shares, sold 263 at $40.14
Rhea-AI Filing Summary
Terri L. Degner, a director of FS Bancorp, Inc. (FSBW), reported transactions dated 08/15/2025. The filing shows an award of 750 restricted shares under the companys 2018 Equity Incentive Plan that vest in three equal annual installments beginning August 15, 2026. The report also records a disposition of 263 common shares at $40.14 per share on the same date. In addition, Ms. Degner was granted 1,500 stock options with an exercise price of $40.14, exercisable beginning August 15, 2026 and expiring August 15, 2035.
The form indicates various beneficial ownership figures reported after the transactions, including entries of 2,500 and 2,237 shares, and notes that 2,000 shares are held jointly with a spouse and 1,323 shares are held indirectly by an IRA. The filing is signed by Ms. Degner on 08/18/2025.
Positive
- Director awarded equity compensation: 750 restricted shares and 1,500 stock options align executive interests with shareholders
- Clear vesting schedule: Awards vest in equal annual installments beginning 08/15/2026, promoting long-term alignment
Negative
- Disposition recorded: 263 shares sold at $40.14, indicating some reduction in direct holdings
- Potential dilution: Grants and options, when vested/exercised, will increase outstanding shares
Insights
TL;DR: Director received equity awards and options with multi-year vesting while disposing of a small block of shares.
The filing documents routine director compensation through restricted stock and option grants under the 2018 Equity Incentive Plan, with vesting beginning one year after grant in equal annual installments of 33.34%. Such grants align the directors interests with long-term shareholder value but also dilute existing holders modestly when vested or exercised. The disposal of 263 shares at $40.14 appears small relative to the awards and likely reflects personal portfolio needs rather than a material change in alignment. The long-dated option expiration (08/15/2035) provides extended time for potential upside, subject to customary dilution and strike-price considerations.
TL;DR: Transactions are standard insider award and sale activity with no single large, market-moving item.
The Form 4 records an award of 750 restricted shares and 1,500 stock options at a $40.14 exercise price, both with vesting starting 08/15/2026. The reported sale of 263 shares at $40.14 is documented and specific beneficial ownership numbers are shown, including joint and IRA holdings. From a market perspective, these volumes are small and the awards are time-locked by vesting, so immediate market impact is likely negligible. Observers should note the exercise price equals the reported sale price, which may reflect grant pricing methodology but is not a projection of future stock performance.